Haimowitz v. Novartis Pharmaceuticals Corp.

OPINION & ORDER

John F. Keenan, United States District Judge:

Before the Court is Defendant Novartis Pharmaceuticals Corporation’s motion for summary judgment pursuant to Federal Rule of Civil Procedure 56. Defendant seeks summary judgment on the ground that Plaintiff Beryl Haimowitz’s tort and warranty claims are untimely under New York law.1 For the reasons that follow, the motion is granted and summary judgment is entered in Defendant’s favor.

I. Background

The following facts are taken from the record following discovery. This case concerns allegations that Plaintiffs use of the drug Aredia…